AAAAAA
Results: 1-25/31
Authors:
YCHOU M
FAUROUS P
SAINTAUBERT B
ROUANET P
QUENET F
ROBERT B
GUERREAU D
SACCAVINI JC
MACH JP
ARTUS JC
PELEGRIN A
Citation: M. Ychou et al., ADJUVANT RADIOIMMUNOTHERAPY TRIAL WITH IODINE-131-LABELED ANTI-CEA MONOCLONAL-ANTIBODY F6 F(AB')(2) AFTER RESECTION OF LIVER METASTASES FROM COLORECTAL-CANCER, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 35-35
Authors:
ROBERT B
DORVILLIUS M
BUCHEGGER F
MANI JC
MACH JP
YCHOU M
ARTUS JC
PELEGRIN A
Citation: B. Robert et al., TUMOR IMMUNOTARGETING WITH BI-PARATOPIC ANTIBODIES DIRECTED AGAINST 2DIFFERENT EPITOPES OF CEA, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 36-36
Authors:
YCHOU M
DUFFOUR J
KRAMAR A
GRENIER J
Citation: M. Ychou et al., VALUE OF SERIAL CARCINOEMBRYONIC ANTIGEN LEVELS IN EVALUATING THE RESPONSE TO CHEMOTHERAPY IN PATIENTS WITH ADVANCED DIGESTIVE CANCERS, Oncology Reports, 5(5), 1998, pp. 1245-1250
Authors:
YCHOU M
KRAMAR A
RAOUL JL
DESSEIGNE F
BOREL C
JACOB H
HUA A
WEINLING E
MERROUCHE Y
Citation: M. Ychou et al., HIGH-DOSE OF CPT-11 (500 MG M(2)) AS FIRST LINE CHEMOTHERAPY FOR METASTATIC COLORECTAL-CANCER - PRELIMINARY-RESULTS OF A MULTICENTER PHASE-II TRIAL/, Annals of oncology, 9, 1998, pp. 181-181
Authors:
CULINE S
FABBRO M
YCHOU M
ROMIEU G
CUPISSOL D
PUJOL H
Citation: S. Culine et al., CHEMOTHERAPY IN CARCINOMAS OF UNKNOWN PRIMARY SITE (CUP) - A HIGH-DOSE INTENSITY POLICY, Annals of oncology, 9, 1998, pp. 231-231
Authors:
SEITZ JF
DUCREUX M
YCHOU M
BONNAY M
ROUGIER P
MIGNARD D
ARMAND JP
Citation: Jf. Seitz et al., PHASE I II STUDY OF CPT-II IN COMBINATION WITH LV5FU2 (DE GRAMONT-REGIMEN) EVERY 2 WEEKS FOR THE TREATMENT OF COLORECTAL-CANCER (CRC) AFTER5-FU FAILURE/, Annals of oncology, 9, 1998, pp. 261-261
Authors:
BECOUARN Y
YCHOU M
DUCREUX M
BOREL C
BERTHEAULTCVITKOVIC F
SEITZ JF
NASCA S
NGUYEN TD
PAILLOT B
RAOUL JL
DUFFOUR J
FANDI A
DUPONTANDRE G
ROUGIER P
Citation: Y. Becouarn et al., PHASE-II TRIAL OF OXALIPLATIN AS FIRST-LINE CHEMOTHERAPY IN METASTATIC COLORECTAL-CANCER PATIENTS, Journal of clinical oncology, 16(8), 1998, pp. 2739-2744
Authors:
YCHOU M
FABBROPERAY P
PERNEY P
MARCAIS O
GOUZE C
RIBARD D
BONSROSSET F
HERAN B
VEYRAC M
BLANC F
Citation: M. Ychou et al., A PROSPECTIVE RANDOMIZED STUDY COMPARING HIGH-DOSE AND LOW-DOSE LEUCOVORIN COMBINED WITH SAME-DOSE 5-FLUOROURACIL IN ADVANCED COLORECTAL-CANCER, American journal of clinical oncology, 21(3), 1998, pp. 233-236
Authors:
CULINE S
GAZAGNE L
YCHOU M
ROMIEU G
FABBRO M
CUPISSOL D
DUBOIS JB
Citation: S. Culine et al., CARCINOMAS OF UNKNOWN PRIMARY SITE - A STUDY BASED ON 100 PATIENTS TREATED AT THE MONTPELLIER-CANCER-CENTER, La Revue de medecine interne (Paris), 19(10), 1998, pp. 713-719
Authors:
YCHOU M
PELEGRIN A
FAUROUS P
ROBERT B
SACCAVINI JC
GUERREAU D
ROSSI JF
FABBRO M
BUCHEGGER F
MACH JP
ARTUS JC
Citation: M. Ychou et al., PHASE-I II RADIO-IMMUNOTHERAPY STUDY WITH IODINE-131-LABELED ANTI-CEAMONOCLONAL-ANTIBODY F6 F(AB')(2) IN PATIENTS WITH NONRESECTABLE LIVERMETASTASES FROM COLORECTAL-CANCER/, International journal of cancer, 75(4), 1998, pp. 615-619
Authors:
YCHOU M
SENESSE P
QUENET F
Citation: M. Ychou et al., GASTROENTEROLOGY, Bulletin du cancer, 85(1), 1998, pp. 37-41
Authors:
ROUGIER P
YCHOU M
SEITZ JF
BONNAY M
MIGNARD D
COUTEAU C
ARMAND JP
DUCREUX M
Citation: P. Rougier et al., PHASE-I II STUDY OF CPT-11 IN COMBINATION WITH LV2FU5 (DE-GRAMONT-REGIMEN) EVERY 2 WEEKS FOR THE TREATMENT OF COLORECTAL-CANCER (CRC) AFTER5FU FAILURE/, European journal of cancer, 33, 1997, pp. 756-756
Authors:
CULINE S
FABBRO M
ASSENS C
YCHOU M
ROMIEU G
KRAMAR A
CUPISSOL D
PINGUET F
PUJOL H
Citation: S. Culine et al., 4-STEP HIGH-DOSE SEQUENTIAL CHEMOTHERAPY WITH HEMATOPOIETIC PROGENITOR-CELL SUPPORT AS INDUCTION TREATMENT FOR PATIENTS WITH SOLID TUMORS, Annals of oncology, 8(10), 1997, pp. 951-956
Authors:
ROUGIER P
BUGAT R
DOUILLARD JY
CULINE S
SUC E
BRUNET P
BECOUARN Y
YCHOU M
MARTY M
EXTRA JM
BONNETERRE J
ADENIS A
SEITZ JF
GANEM G
NAMER M
CONROY T
NEGRIER S
MERROUCHE Y
BURKI F
MOUSSEAU M
HERAIT P
MAHJOUBI M
Citation: P. Rougier et al., PHASE-II STUDY OF IRINOTECAN IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER IN CHEMOTHERAPY-NAIVE PATIENTS AND PATIENTS PRETREATED WITH FLUOROURACIL-BASED CHEMOTHERAPY, Journal of clinical oncology, 15(1), 1997, pp. 251-260
Authors:
JOULIA JM
PINGUET F
YCHOU M
DUFFOUR J
TOPART D
GROSSE PY
ASTRE C
BRESSOLLE F
Citation: Jm. Joulia et al., PHARMACOKINETICS OF 5-FLUOROURACIL (5-FURA) IN PATIENTS WITH METASTATIC COLORECTAL-CANCER RECEIVING 5-FURA BOLUS PLUS CONTINUOUS-INFUSION WITH HIGH-DOSE FOLINIC ACID (LV5FU2), Anticancer research, 17(4A), 1997, pp. 2727-2730
Authors:
NGUYEN TD
THEOBALD S
ROUGIER P
DUCREUX M
LUSINCHI A
BARDET E
EYMARD JC
CONROY T
FRANCOISE E
SEITZ JF
BUGAT R
YCHOU M
Citation: Td. Nguyen et al., SIMULTANEOUS HIGH-DOSE EXTERNAL IRRADIATION AND DAILY CISPLATIN IN UNRESECTABLE, NONMETASTATIC ADENOCARCINOMA OF THE PANCREAS - A PHASE I-II STUDY, Radiotherapy and oncology, 45(2), 1997, pp. 129-132
Authors:
SENESSE P
YCHOU M
DEBRIGODE C
ROUANET P
QUENET F
SALAS S
SAINTAUBERT B
KRAMAR A
ASTRE C
SIMONYFONTAINE J
DUBOIS JB
Citation: P. Senesse et al., PREOPERATIVE CHEMOTHERAPY AND CONCURRENT IRRADIATION FOR LOCALIZED ESOPHAGEAL-CARCINOMA - RESULTS OF A PHASE-II STUDY, Gastroenterology, 112(4), 1997, pp. 653-653
Authors:
YCHOU M
Citation: M. Ychou, IS THERE A NEED FOR INDUCTION TREATMENT O F OPERABLE CARDIA CANCERS, Bulletin du cancer, 84(10), 1997, pp. 988-990
Authors:
YCHOU M
ASTRE C
ROUANET P
FABRE JM
SAINTAUBERT B
DOMERGUE J
RIBARD D
CIURANA AJ
JANBON C
PUJOL H
Citation: M. Ychou et al., A PHASE-II STUDY OF 5-FLUOROURACIL, LEUCOVORIN AND CISPLATIN (FLP) FOR METASTATIC GASTRIC-CANCER, European journal of cancer, 32A(11), 1996, pp. 1933-1937
Authors:
MACHOVER D
DIAZRUBIO E
DEGRAMONT A
SCHILF A
GASTIABURU JJ
BRIENZA S
ITZHAKI M
METZGER G
NDAW D
VIGNOUD J
ABAD A
FRANCOIS E
GAMELIN E
MARTY M
SASTRE J
SEITZ JF
YCHOU M
Citation: D. Machover et al., 2 CONSECUTIVE PHASE-II STUDIES OF OXALIPLATIN (L-OHP) FOR TREATMENT OF PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA WHO WERE RESISTANT TO PREVIOUS TREATMENT WITH FLUOROPYRIMIDINES, Annals of oncology, 7(1), 1996, pp. 95-98
Authors:
EXTRA JM
ROUGIER P
YCHOU M
DOUILLARD JY
ADENIS A
MOUSSEAU M
ASSADOURIAN S
MAHJOUBI M
MARTY M
Citation: Jm. Extra et al., A PHASE-II STUDY OF CPT-11 (IRINOTECAN) IN REFRACTORY TO 5-FU COLORECTAL-CANCER (CRC) WITH, PREVENTIVE TREATMENT OF DELAYED DIARRHEA BY ACETORPHAN, European journal of cancer, 31A, 1995, pp. 727-727
Authors:
YCHOU M
FAUROUS P
PELEGRIN A
SAINTAUBERT B
ROUANET P
SACCAVINI JC
GUERREAU D
MACH JP
DUBOIS JB
ARTUS JC
Citation: M. Ychou et al., RADIOIMMUNOTHERAPY OF METASTATIC COLON-CANCER - PHASE-I STUDY WITH ANTI-CEA F(AB)'(2) FRAGMENTS LABELED WITH ESCALATING DOSE OD IODINE 131, European journal of cancer, 31A, 1995, pp. 755-755
Authors:
YCHOU M
Citation: M. Ychou, IS NEOADJUVANT CHEMOTHERAPY NECESSARY IN CANCER OF THE STOMACH, Annales de Gastroenterologie et d'Hepatologie, 31(2), 1995, pp. 132-133
Authors:
YCHOU M
VEYRAC M
HANSLIK B
ABOUHAFSS M
DAURES JP
PERNEY P
PINTO J
BRUEL JM
BLANC F
MICHEL H
Citation: M. Ychou et al., PROGNOSTIC FACTORS OF HEPATOCELLULAR-CARC INOMA - A MULTIVARIATE-ANALYSIS IN 113 PATIENTS, Bulletin du cancer, 82(11), 1995, pp. 971-974
Authors:
ROUANET P
FABRE JM
DUBOIS JB
DRAVET F
SAINTAUBERT B
PRADEL J
YCHOU M
SOLASSOL C
PUJOL H
Citation: P. Rouanet et al., CONSERVATIVE SURGERY FOR LOW RECTAL-CARCINOMA AFTER HIGH-DOSE RADIATION - FUNCTIONAL AND ONCOLOGIC RESULTS, Annals of surgery, 221(1), 1995, pp. 67-73